Table of Contents

company-logo

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for COVID-19 T cell vaccine development; and research agreement with Regeneron. The company was formerly known as Vaccibody AS. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.

Nykode Therapeutics Dividend Announcement

• Nykode Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Nykode Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Nykode Therapeutics Dividend History

Nykode Therapeutics Dividend Yield

Nykode Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Nykode Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Nykode Therapeutics Financial Ratios

P/E ratio-0.26
PEG ratio-0.03
P/B ratio0.55
ROE-26.39%
Payout ratio0.00%
Current ratio9.28
Quick ratio9.28
Cash Ratio9.05

Nykode Therapeutics Dividend FAQ

Does Nykode Therapeutics stock pay dividends?
Nykode Therapeutics does not currently pay dividends to its shareholders.
Has Nykode Therapeutics ever paid a dividend?
No, Nykode Therapeutics has no a history of paying dividends to its shareholders. Nykode Therapeutics is not known for its dividend payments.
Why doesn't Nykode Therapeutics pay dividends?
There are several potential reasons why Nykode Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Nykode Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Nykode Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Nykode Therapeutics a dividend aristocrat?
Nykode Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Nykode Therapeutics a dividend king?
Nykode Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Nykode Therapeutics a dividend stock?
No, Nykode Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Nykode Therapeutics stocks?
To buy Nykode Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Nykode Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.